Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Journal of Surgical Oncology
|
January 6, 2015
Survivorship
Douglas J Harrison, Cindy Schwartz
Pediatric Blood & Cancer
|
February 13, 2008
Allogeneic stem cell transplantation in a patient with relapsed Ewing sarcoma
Kenneth G Lucas, Cindy Schwartz, Joel Kaplan
Transfusion Medicine Reviews
|
January 15, 2002
Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions
Alison M Friedmann, Haydar Sengul, Harold Lehmann, et al.
Seminars in Radiation Oncology
|
August 7, 2003
Radiation-associated cardiovascular disease: manifestations and management
M Jacob Adams, Steven E Lipshultz, Cindy Schwartz, et al.
Journal of Medical Virology
|
September 13, 2002
Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease
Pauline Meij, Marcel B H J Vervoort, Elisabeth Bloemena, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2007
American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects
Joseph R Carver, Charles L Shapiro, Andrea Ng, et al.
British Journal of Haematology
|
June 11, 2019
Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children's Oncology Group
Kara M Kelly, Peter D Cole, Qinglin Pei, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 22, 2016
Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 Trial
Anne-Marie Charpentier, Debra L Friedman, Suzanne Wolden, et al.
Pediatric Blood & Cancer
|
August 23, 2012
Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group
Cameron K Tebbi, Nancy P Mendenhall, Wendy B London, et al.
Antimicrobial Agents and Chemotherapy
|
July 29, 2005
Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients
Nita L Seibel, Cindy Schwartz, Antonio Arrieta, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Journal of Surgical Oncology
|
January 6, 2015
Survivorship
Douglas J Harrison, Cindy Schwartz
Pediatric Blood & Cancer
|
February 13, 2008
Allogeneic stem cell transplantation in a patient with relapsed Ewing sarcoma
Kenneth G Lucas, Cindy Schwartz, Joel Kaplan
Transfusion Medicine Reviews
|
January 15, 2002
Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions
Alison M Friedmann, Haydar Sengul, Harold Lehmann, et al.
Seminars in Radiation Oncology
|
August 7, 2003
Radiation-associated cardiovascular disease: manifestations and management
M Jacob Adams, Steven E Lipshultz, Cindy Schwartz, et al.
Journal of Medical Virology
|
September 13, 2002
Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease
Pauline Meij, Marcel B H J Vervoort, Elisabeth Bloemena, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2007
American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects
Joseph R Carver, Charles L Shapiro, Andrea Ng, et al.
British Journal of Haematology
|
June 11, 2019
Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children's Oncology Group
Kara M Kelly, Peter D Cole, Qinglin Pei, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 22, 2016
Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 Trial
Anne-Marie Charpentier, Debra L Friedman, Suzanne Wolden, et al.
Pediatric Blood & Cancer
|
August 23, 2012
Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group
Cameron K Tebbi, Nancy P Mendenhall, Wendy B London, et al.
Antimicrobial Agents and Chemotherapy
|
July 29, 2005
Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients
Nita L Seibel, Cindy Schwartz, Antonio Arrieta, et al.
Page
of 2